1 of 3 listed pharmas spends 40% of their sales into SG&A
It was observed 1 of 3 listed pharmaceutical companies had a SG&A(selling, general and administrative) expense/sales ratio more than 40%. The ratio that is higher than other industries has worked as an obstacle of increasing profitability.
Yakup Shinmoon(www.yakup.com) analyzed 60 KOSPI and KOSD...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
